Cargando…

Chemotherapy resistance and stromal targets in breast cancer treatment: a review

Therapy resistance is a known problem in breast cancer and is associated with a variety of mechanisms. The role of the tumor microenvironment in cancer development and resistance mechanisms is becoming increasingly understood. Tumor–stroma is the main component of the tumor microenvironment. Stromal...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Spek, Y. M., Kroep, J. R., Tollenaar, R. A. E. M., Mesker, Wilma E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588379/ https://www.ncbi.nlm.nih.gov/pubmed/33006013 http://dx.doi.org/10.1007/s11033-020-05853-1

Ejemplares similares

Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2‐negative early breast cancer
por: Hagenaars, Sophie C., et al.
Publicado: (2021)

Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content
por: Sandberg, Tessa P., et al.
Publicado: (2018)

Erratum: Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content
por: Sandberg, Tessa P., et al.
Publicado: (2019)

Tumor stroma as contributing factor in the lymph node metastases process?
por: Mesker, Wilma E., et al.
Publicado: (2019)

Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures
por: Velstra, Berit, et al.
Publicado: (2012)

The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage
por: Mesker, Wilma E., et al.
Publicado: (2007)

Stromal Targets for Fluorescent-Guided Oncologic Surgery
por: Boonstra, Martin C., et al.
Publicado: (2015)

Serum N-glycan profiles differ for various breast cancer subtypes
por: Vreeker, Gerda C. M., et al.
Publicado: (2021)

The Stroma Liquid Biopsy Panel Contains a Stromal-Epithelial Gene Signature Ratio That Is Associated with the Histologic Tumor-Stroma Ratio and Predicts Survival in Colon Cancer
por: Ravensbergen, Cor J., et al.
Publicado: (2021)

Detection of Tumor Cells in Bone Marrow, Peripheral Blood and Lymph Nodes by Automated Imaging Devices
por: Mesker, Wilma E., et al.
Publicado: (2006)

Identification of Human Serum Peptides in Fourier Transform Ion Cyclotron Resonance Precision Profiles
por: Nicolardi, Simone, et al.
Publicado: (2012)

Standardization of the tumor-stroma ratio scoring method for breast cancer research
por: Hagenaars, Sophie C., et al.
Publicado: (2022)

The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review
por: Kramer, C. J. H., et al.
Publicado: (2018)

The intra-tumoural stroma in patients with breast cancer increases with age
por: Vangangelt, Kiki M. H., et al.
Publicado: (2019)

Automated Plasma Glycomics with Linkage-Specific Sialic Acid Esterification and Ultrahigh Resolution MS
por: Vreeker, Gerda C. M., et al.
Publicado: (2018)

Serum N-glycome alterations in colorectal cancer associate with survival
por: de Vroome, Stefan W., et al.
Publicado: (2018)

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer
por: Zunder, Stéphanie M., et al.
Publicado: (2018)

Serum N-Glycosylation RPLC-FD-MS Assay to Assess Colorectal Cancer Surgical Interventions
por: Moran, Alan B., et al.
Publicado: (2023)

Proteomic Serum Biomarkers and Their Potential Application in Cancer Screening Programs
por: Huijbers, Anouck, et al.
Publicado: (2010)

Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer
por: Sandberg, Tessa P., et al.
Publicado: (2019)

Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer
por: Ravensbergen, Cor J., et al.
Publicado: (2021)

The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer
por: Vangangelt, Kiki M.H., et al.
Publicado: (2020)

Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
por: Smit, Marloes A., et al.
Publicado: (2021)

Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach
por: Dekker, Tim JA, et al.
Publicado: (2012)

Application of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort()()
por: Potjer, Thomas P., et al.
Publicado: (2016)

Anti‐stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma
por: Carapuça, Elisabete F, et al.
Publicado: (2016)

Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer
por: Mesker, W E, et al.
Publicado: (2015)

Characteristics of tumour stroma in regional lymph node metastases in colorectal cancer patients: a theoretical framework for future diagnostic imaging with FAPI PET/CT
por: Polack, Meaghan, et al.
Publicado: (2022)

Development of Tier 2 LC-MRM-MS protein quantification methods for liquid biopsies
por: Diederiks, Nina, et al.
Publicado: (2022)

Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study
por: Vogelaar, F Jeroen, et al.
Publicado: (2010)

Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study
por: Smit, Marloes, et al.
Publicado: (2019)

e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study
por: Smit, Marloes A, et al.
Publicado: (2021)

The role of artificial intelligence to quantify the tumour-stroma ratio for survival in colorectal cancer
por: Smit, Marloes A, et al.
Publicado: (2020)

Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer
por: Hanna-Sawires, Randa G., et al.
Publicado: (2021)

High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer
por: Wang, Tingting, et al.
Publicado: (2016)

Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?
por: Charehbili, Ayoub, et al.
Publicado: (2013)

Illness Perceptions in Women with Breast Cancer—a Systematic Literature Review
por: Kaptein, Ad A., et al.
Publicado: (2015)

RNF12 is regulated by AKT phosphorylation and promotes TGF-β driven breast cancer metastasis
por: Huang, Yongsheng, et al.
Publicado: (2022)

Serum N‐Glycome analysis reveals pancreatic cancer disease signatures
por: Vreeker, Gerda C. M., et al.
Publicado: (2020)

A Matrix-Assisted Laser Desorption/Ionization—Mass Spectrometry Assay for the Relative Quantitation of Antennary Fucosylated N-Glycans in Human Plasma
por: Rebello, Osmond D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rjn5hlo3jjkn6ukchjicmhbm3j